Product Details
Home / Products / SARS-CoV-2 / The Overall Solution To Nucleic Acid Detection of SARS-CoV-2
Share to:

The Overall Solution To Nucleic Acid Detection of SARS-CoV-2

Detection of SARS-CoV-2

Product Overview

SARS-CoV-2 and COVID-19

The Coronavirus disease ( COVID-19) pandemic has caused serious harm to human life and health, and has also seriously disrupted normal social and economic activities. COVID-19 is pneumonia caused by SARS-CoV-2 infection and can be spread through respiratory droplets and contact.SARS-CoV-2 is an enveloped single-stranded plus RNA virus belonging to the Coronaviridae family. It was named 2019-nCoV by The World Health Organization temporarily.


Related guidelines and consensus

After the outbreak of COVID-19, authoritative organizations such as the World Health Organization(WHO), National Health Commission of the People’s Republic of China(NHC), and Chinese Center for Disease Control and Prevention have successively issued relevant guidelines and recommended nucleic acid detection techniques, especially fluorescent PCR method as the main diagnostic standard for COVID-19. For the diagnostic products of COVID-19, the United States food and drug administration (US FDA) lifted the restriction on emergency use authorization application.


TianLong overall solution to nucleic acid detection of SARS-CoV-2

Based on deep technical accumulation and years of rich experience in preventing and controlling sudden outbreak of epidemics, TianLong quickly developed SARS-CoV-2 nucleic acid detection reagent (fluorescent PCR method) within 72 hours of the publication of the genome sequence of SARS-CoV-2 and obtained the EU CE certification, and then launched the overall solution to nucleic acid detection of SARS-CoV-2,including series of products for sample collection, nucleic acid extraction and nucleic acid detection, etc.The total solution of TianLong has been applied in more than 20 countries and regions including China, South Korea, Japan, Singapore, Thailand, Italy, UAE, France, Denmark, Turkey, and Kazakhstan.


Detection Process


Advantages of TianLong’s solution

Accurate and reliable results:

It is based on fluorescent PCR method, and uses multiple targets , and it also has a internal control which can avoid false negative results.

Strong security guarantee:

 The virus can be inactivated when it is sampled. A variety of measures such as rotary nucleic acid extraction,drop catcher technology,experimental partitioning,ultraviolet disinfection, and air filtration are used to prevent pollution and ensure the safety of operators.

Convenient operation:

Automated operation only takes about 2 hours to test 96 samples.So it is suitable for screening and testing of large-scale samples in epidemic prevention and control.

Certification authority:

Related products have obtained authoritative certifications from China NMPA, the US FDA,South Korea FDA, EU CE and International CB, etc.

overall solution:

The solution includes a full set of equipments and reagents for sample collection, nucleic acid extraction, and fluorescent PCR detection, which can meet different needs of users.


Clinical Significance of COVID-19 Nucleic Acid Detection

Monitoring epidemiological datas.

Assisting in the diagnosis of COVID-19 and preventing delayed treatment.

Identifying viral types of respiratory tract inflections,and adjusting the diagnosis and treatment strategies in time.